Literature DB >> 24844855

[Health technology assessment (HTA). Developments in healthcare and potential for radiology].

E R Gizewski1, M Forsting, G A Krombach, O Schöffski.   

Abstract

CLINICAL/METHODICAL ISSUE: Cost-intensive measures and procedures, such as also employed in radiology, have far-reaching economic implications in respect to increasing expenditure with limited resources. STANDARD RADIOLOGICAL
METHODS: Health technology assessment (HTA) describes the systematic evaluation of medical procedures and technologies which in recent years has been introduced by many countries into healthcare politics. ASSESSMENT: In many cases HTA analyses can be directly implemented into practice as shown by the examples given in this article; however, in the current form of HTA the practical implementation for radiology often presents the problem that the cost-benefit ratio does not yet have a comprehensive view in the HTA report but is limited to a subsection, e.g. current costs versus sensitivity of a method. Since its inception radiology has had a high power of innovation and new developments will also substantially determine the future years. These procedures must not only be evaluated with respect to feasibility but also in the sense of the HTA in the total concept. PRACTICAL RECOMMENDATIONS: In radiology there are also a large number of possibilities for radiologists not only as passive consumers of HTA reports but also to become active participants in this process, an opportunity which should be taken advantage of.

Entities:  

Mesh:

Year:  2014        PMID: 24844855     DOI: 10.1007/s00117-014-2695-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  20 in total

1.  Health technology assessment in Germany. Status, challenges, and development.

Authors:  M Perleth; R Busse
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

2.  Best practice in undertaking and reporting health technology assessments. Working group 4 report.

Authors:  Marcial Velasco; Matthias Perleth; Michael Drummond; Felix Gürtner; Torben Jørgensen; Albert Jovell; Jim Malone; Alric Rüther; Claudia Wild
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

3.  Health technology assessment implementation: the politics of ethics.

Authors:  Daniel Callahan
Journal:  Med Decis Making       Date:  2011-10-26       Impact factor: 2.583

4.  Health technology assessment: decentralized and fragmented in the US compared to other countries.

Authors:  S Perry; M Thamer
Journal:  Health Policy       Date:  1997-06       Impact factor: 2.980

5.  Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.

Authors:  Finn Børlum Kristensen; Kristian Lampe; Deborah L Chase; Sun Hae Lee-Robin; Claudia Wild; Montse Moharra; Marcial Velasco Garrido; Camilla Palmhøj Nielsen; John-Arne Røttingen; Susanna Allgurin Neikter; Marie Louise Bistrup
Journal:  Int J Technol Assess Health Care       Date:  2009-12       Impact factor: 2.188

6.  Health technology assessment and private payers' coverage of personalized medicine.

Authors:  Julia R Trosman; Stephanie L Van Bebber; Kathryn A Phillips
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

7.  [Imaging center - optimization of the imaging process].

Authors:  H-P Busch
Journal:  Rofo       Date:  2013-01-11

8.  [Health-economic evaluation of magnetic resonance imaging before biopsy for diagnosis of prostate cancer].

Authors:  A Stadlbauer; R Bernt; E Salomonowitz; E Plas; G Strunk; K Eberhardt
Journal:  Rofo       Date:  2011-08-23

Review 9.  An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Authors:  P Auguste; P Barton; C Hyde; T E Roberts
Journal:  Health Technol Assess       Date:  2011-04       Impact factor: 4.014

10.  Methods for assessment of innovative medical technologies during early stages of development.

Authors:  Marc Bartelmes; Ulrike Neumann; Dagmar Lühmann; Matthias P Schönermark; Anja Hagen
Journal:  GMS Health Technol Assess       Date:  2009-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.